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Abstract 
Objective: This case report highlights the risk of Torsade de Pointes (TdP), a 
life threatening cardiac arrhythmia in a heroin dependent patient receiving 
methadone substitution therapy who was prescribed erythromycin for upper 
respiratory tract infection. Method: We report a case of a 35-year-old Malay 
man on methadone maintenance treatment who developed TdP possibly due 
to drug interaction between methadone and erythromycin. Results: The 
patient reported feeling unwell, chest pain and feeling dizzy after consuming 
2 doses of erythromycin. ECG monitoring showed prolonged rate-corrected 
QT interval leading to TdP. The patient was admitted to the ward where the 
cardiac arrhythmia ceased following methadone discontinuation. This 
cardiac arrhythmia was most likely due to drug interaction between 
methadone and erythromycin (an enzyme inhibitor) which led to an increase 
in methadone concentration and potentiated the adverse effects. Conclusion: 
As methadone is a beneficial treatment for heroin dependent patients, the 
risk of cardiac arrhythmia is of great concern. To avoid complications of 
drug interaction, patients on methadone therapy should be advised to seek 
medical assessment before taking other drugs. As TdP is life threatening, it is 
thus important that physicians and psychiatrists involved in the treatment of 
heroin dependent patients on methadone substitution therapy be made aware 
of this risk. ASEAN Journal of Psychiatry, Vol.11 (1): Jan – June 2010: XX 
XX. 
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Introduction 
Opiate substitution therapy with methadone 
has been introduced as a pharmacological 
treatment option for heroin dependent  
individuals in Malaysia recently [1]. 
Methadone, approved by the FDA in 1947, 
has been widely studied and prescribed, and 
has proven to be an established and effective 
pharmacological agent to treat heroin 
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dependent patients worldwide [2]. However, 
in recent years, the literature has 
documented cases of methadone associated 
cardiac arrhythmias [2, 3]. Most of these 
cases were reported among Caucasians, and 
thus far there has not been any reported 
incidence in Malay man. This case report 
highlights the case of a heroin dependent 
man on methadone substitution therapy who 
developed prolonged rate-corrected QT 
interval (QTc) and Torsade de Pointes (TdP) 
following concomitant administration of 
erythromycin. 
Case  Report  
A 35-year-old Malay man presented to the 
accident and emergency department 
complaining of feeling unwell, chest pain 
and feeling dizzy, but no loss of 
consciousness. He also had fever and cough 
for 2 days and had visited his general 
practitioner who had prescribed 
erythromycin a day earlier. His fever and 
cough had subsided, but he complained of 
the onset of these new symptoms after 
taking the second dose of erythromycin. A 
review of his past medical history revealed 
that he was a previous intravenous heroin 
user who was attending a community 
methadone substitution programme for the 
past 8 months. He was prescribed syrup 
methadone 110 mg daily and claimed to be 
responding well to the community opiate 
substitution programme as he was heroin-
free for the last 6 months. He denied any 
side effect or medical problem since taking 
methadone. He was not known to have 
cardiac, respiratory, hepatic or neurological 
disease. He was also not known to have any 
major mental health problem. He was 
married with 2 children and worked as a 
security guard. He stayed in a rented 
apartment and smoked 14 cigarettes per day.  
Physical examination revealed a conscious 
but lethargic looking man with normal vital 
signs and with no cardiovascular, respiratory 
or neurological abnormalities. Continuous 
electrocardiogram (ECG) monitoring at the 
emergency department showed sinus rhythm 
with a QTc interval of 520 ms 
(milliseconds) leading to Torsade de Pointes 
(TdP), but resolved spontaneously. Blood 
investigations revealed normal blood count 
and serum electrolytes, normal liver 
function, normal renal function and normal 
cardiac enzymes. He was admitted to the 
cardiac ward for monitoring, prescribed 
potassium and magnesium supplements, and 
methadone was discontinued and changed to 
buprenorphine. The patient’s cardiovascular 
status remained stable and subsequent ECG 
monitoring after methadone cessation were 
normal. The patient was discharged with 
buprenorphine and a follow-up at the 
cardiology clinic 3 months and 6 months 
later revealed no further cardiac symptoms 
with a normal ECG. This case report was 
written after obtaining informed consent 
from the patient who agreed with the 
condition of strict anonymity that may not 
implicate him. 
Discussion 
In recent years, the literature has 
documented reports of methadone induced 
cardiac arrhythmias [2-4]. Most of these 
cases were reported among Caucasian 
heroin dependent patients, and thus far, the 
authors are not aware of such incidence in a  
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Malay man. In this case report, the authors 
would like to highlight the risk of cardiac 
arrhythmias, in particular QTc interval 
prolongation leading to Torsade de Pointes 
(TdP) in a heroin-dependent patient 
receiving methadone substitution therapy.  
Torsade de Pointes (TdP) has unique ECG 
characteristics of twisting of the QRS 
complex around the isoelectric line. It is 
associated with prolonged QT interval, 
which may degenerate into sustained 
ventricular tachycardia and life threatening 
ventricular fibrillation. Among the known 
predisposing factors for acquired Torsade de 
Pointes (TdP) include an underlying cardiac 
or liver abnormality, electrolyte imbalance 
(hypokalaemia and hypomagnesaemia) and 
drugs (methadone, phenothiazines, tricyclic 
antidepressants and some antibiotics). The 
mechanism by which methadone induced 
cardiac arrhythmia was thought to be due to 
blockade of cardiac K+ channel [2]. As a 
consequence, the QT interval becomes 
prolonged and this may precipitate 
ventricular arrhythmias. In the above 
patient, the normalization of the ECG 
following methadone cessation suggests that 
the Torsade de Pointes (TdP) was most  
likely caused by methadone as the patient 
had no other risk factors. A similar finding 
was also reported in the literature where the 
QT interval returned to normal within 24 
hours following discontinuation of 
methadone [4]. 
Methadone is metabolized in the liver by the 
cytochrome enzyme CYP3A4. Inhibition of 
the CYP3A4 system may lead to an increase 
in methadone concentration and cause 
adverse effects [5]. Some of the known 
CYP3A4 inhibitors include antibiotics (e.g., 
fluoroquinolones and macrolides), 
antihistamines (terfenadine) and psychiatric 
drugs (e.g., haloperidol and chlorpromazine) 
(Table 1) [6]. The patient above had 
consumed erythromycin. Erythromycin, an 
enzyme inhibitor may have caused an 
increase in methadone concentration, 
leading to risk of cardiac blockade and risk 
of ventricular arrythmias [7]. Furthermore, 
erythromycin alone has been reported to 
cause QTc prolongation and provoke TdP, 
although other macrolides such as 
clathromycin had lesser risk of TdP but 
azithromycin did not [8]. The patient above 
however did not have any major mental 
health problem and was not on any 
psychiatric drugs. 
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Table 1: Examples of psychiatric drugs associated with Torsade de Pointes (this list is not comprehensive) 
[6] 
Amitriptyline  
Nortriptyline  
Imipramine  
Desipramine   
Thioridazine  
Chlorpromazine  
Haloperidol   
Droperidol   
Clomipramine Maprotiline  
Doxepin  
Lithium  
Chloral hydrate 
Sertindole  
Pimozide   
Ziprasidone 
 
Cases of methadone induced QTc 
prolongation and Torsade de Pointes (TdP) 
were more often reported in patients on high 
dose methadone above 400 mg daily [2, 3]. 
It should be noted that the above patient 
developed ventricular arrhythmia on a lower 
dose of 110 mg daily. This is probably due 
to drug interaction between methadone and 
erythromycin, where the inhibitory effect of 
erythromycin caused an increase in 
methadone concentration and thus causing 
the adverse effects. In the case above, 
although concern is raised regarding the 
inhibitory effect of erythromycin in patients 
receiving methadone, it is also pertinent to 
mention the potential benefits of the 
immunomodulatory effects of macrolides for 
treating pulmonary infections which is 
commonly encountered in patients receiving 
methadone maintenance therapy [9]. 
Although methadone has been reported to 
induce ventricular arrhythmias, the small 
risk of Torsade de Pointes (TdP) should not 
deter physicians or psychiatrists from 
offering methadone as a treatment option to 
heroin dependent individuals. In clinical 
practice, the adverse effects of QT 
prolonging drugs such as methadone can be 
prevented by avoiding its use in patients 
with pre-existing heart disease or risk factors 
as mentioned above, and/or electrolyte 
imbalance such as hypokalaemia. It should 
be emphasized that the risk of cardiac 
arrhythmia arises with the concurrent 
presence of other risk factors. Physicians 
and psychiatrists dealing with patients on 
methadone therapy should thus be alert to 
underlying medical diseases that may put 
patients on methadone at risk of cardiac 
arrhythmias, be vigilant to the potential of 
drug interaction between methadone and 
other drugs and cautious of electrolyte 
imbalance such as hypokalaemia (diarrhoea 
or vomiting and use of diuretics). Patients on 
methadone should be educated to seek 
medical advice before ingesting other drugs 
and to seek medical treatment and 
assessment if they experience chest 
discomfort, palpitations or dizziness. Part of 
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the evaluation of these patients should also 
include an electrocardiogram. In patients 
who experienced methadone induced 
arrhythmias, methadone should be stopped 
and an alternative safer medication such as 
buprenorphine, which is a partial opioid 
agonist should be considered. Any adverse 
event suggestive of cardiac arrhythmias 
should be reported urgently to drug safety 
authorities. 
Conflict of interest: The authors have given 
seminars pertaining to methadone and 
buprenorphine. 
 
References: 
1.  NM Noordin, MI Merican, HA 
Rahman, SS Lee, R Ramly. Substitution 
treatment in Malaysia. Lancet, 2008. 
372(9644): 1149-50. 
2. Kornick, C. A., Kilborn, M. J., 
Santiago-Palma, J., Schulman, G., Thaler, 
H. T., Keefe, D. L.et. al. QTc interval 
prolongation associated with intravenous 
methadone. Pain, 2003. 105(3): 499-506. 
3. Martell, B., Arsten, JH., Krantz, MJ., 
Gourevitch, MN. Impact of methadone 
treatment on cardiac repolarisation and 
conduction in opioid users. Am J Cardiol, 
2005. 2005(95):  915-918. 
4. Walker, P.W., Klein, D, Kasza, L. 
High dose methadone and ventricular 
arrythmias: a report of 3 cases. Pain, 2003. 
103: 321-324. 
5. Michalets, E.L.. Update: clinically 
significant cytochrome P-450 drug 
interactions. Pharmacotherapy, 1998. 18(1): 
84-112. 
6. Yap, Y.G. and A.J. Camm. Drug 
induced QT prolongation and torsades de 
pointes. Heart, 2003. 89(11): 1363-72. 
7. Michalets, E.L., L.K. Smith, and 
E.D. Van Tassel. Torsade de pointes 
resulting from the addition of droperidol to 
an existing cytochrome P450 drug 
interaction. Ann Pharmacother, 1998. 32(7-
8): 761-5. 
8. Milberg, P, Eckardt, L, Bruns, H. J, 
Biertz, J, Ramtin, S, Reinsch, N et. al. 
Divergent proarrhythmic potential of 
macrolide antibiotics despite similar QT 
prolongation: fast phase 3 repolarization 
prevents early after depolarizations and 
torsade de pointes. J Pharmacol Exp Ther, 
2002. 303(1): 218-25. 
9. Siddiqui, J. Immunomodulatory 
effects of macrolides: implications for 
practicing clinicians. Am J Med, 2004. 117 
Suppl 9A: 26S-29S. 
Corresponding Author: Noor Zurani Md Haris Robson, Department of Primary Care 
Medicine. Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur.……………... 
………………… 
Email: noorzurani@um.edu.my 
            noorzurani@ummc.edu.my 
 
Received: 4 August 2009              Accepted: 12 August 2009 
ERYTHROMYCIN INDUCED TORSADE DE POINTES IN A METHADONE MAINTENANCE PATIENT: CASE REPORT 
ASEAN Journal of Psychiatry, Vol.11 (1): Jan – June 2010: XX XX
5
